165 related articles for article (PubMed ID: 38811083)
1. Amyloid fibril cytotoxicity and associated disorders.
Saremi S; Khajeh K
Prog Mol Biol Transl Sci; 2024; 206():265-290. PubMed ID: 38811083
[TBL] [Abstract][Full Text] [Related]
2. Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses.
Zhang X; Sun XX; Xue D; Liu DG; Hu XY; Zhao M; Yang SG; Yang Y; Xia YJ; Wang Y; Liu RT
Biochim Biophys Acta; 2011 Dec; 1814(12):1703-12. PubMed ID: 21979582
[TBL] [Abstract][Full Text] [Related]
3. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.
Liberta F; Loerch S; Rennegarbe M; Schierhorn A; Westermark P; Westermark GT; Hazenberg BPC; Grigorieff N; Fändrich M; Schmidt M
Nat Commun; 2019 Mar; 10(1):1104. PubMed ID: 30846696
[TBL] [Abstract][Full Text] [Related]
4. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
5. Amyloidosis and Amyloidogenesis: One Name, Many Diseases.
Pozzan M; Indennidate C; Varrà GG; Sinagra G; Merlo M; Pagura L
Heart Fail Clin; 2024 Jul; 20(3):249-260. PubMed ID: 38844296
[TBL] [Abstract][Full Text] [Related]
6. Cryo-EM structure of a human LECT2 amyloid fibril reveals a network of polar ladders at its core.
Richards LS; Flores MD; Zink S; Schibrowsky NA; Sawaya MR; Rodriguez JA
Structure; 2023 Nov; 31(11):1386-1393.e3. PubMed ID: 37657439
[TBL] [Abstract][Full Text] [Related]
7. A brief overview of amyloids and Alzheimer's disease.
Ow SY; Dunstan DE
Protein Sci; 2014 Oct; 23(10):1315-31. PubMed ID: 25042050
[TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical insights into protein misfolding and associated amyloidosis.
Pande M; Srivastava R
Eur J Med Chem; 2019 Dec; 184():111753. PubMed ID: 31622853
[TBL] [Abstract][Full Text] [Related]
9. Why are Functional Amyloids Non-Toxic in Humans?
Jackson MP; Hewitt EW
Biomolecules; 2017 Sep; 7(4):. PubMed ID: 28937655
[TBL] [Abstract][Full Text] [Related]
10. Methods to study the structure of misfolded protein states in systemic amyloidosis.
Fändrich M; Schmidt M
Biochem Soc Trans; 2021 Apr; 49(2):977-985. PubMed ID: 33929491
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the amyloid fibril from primary localized cutaneous nodular amyloidosis associated with Sjögren's syndrome.
Inazumi T; Hakuno M; Yamada H; Tanaka M; Naka W; Tajima S; Harada T; Nishikawa T
Dermatology; 1994; 189(2):125-8. PubMed ID: 8075437
[TBL] [Abstract][Full Text] [Related]
12. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
13. [Amyloidosis: a model of misfolded protein disorder].
Grateau G; Verine J; Delpech M; Ries M
Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
[TBL] [Abstract][Full Text] [Related]
14. Current Understanding of Systemic Amyloidosis and Underlying Disease Mechanisms.
Picken MM
Am J Cardiol; 2022 Dec; 185 Suppl 1():S2-S10. PubMed ID: 36549788
[TBL] [Abstract][Full Text] [Related]
15. [Characterization of amyloidosis].
Yazaki M; Ikeda S
Brain Nerve; 2014 Jul; 66(7):723-30. PubMed ID: 24998817
[TBL] [Abstract][Full Text] [Related]
16. Mouse senile amyloid fibrils deposited in skeletal muscle exhibit amyloidosis-enhancing activity.
Qian J; Yan J; Ge F; Zhang B; Fu X; Tomozawa H; Sawashita J; Mori M; Higuchi K
PLoS Pathog; 2010 May; 6(5):e1000914. PubMed ID: 20502680
[TBL] [Abstract][Full Text] [Related]
17. Amyloid in surgical pathology.
Röcken C; Sletten K
Virchows Arch; 2003 Jul; 443(1):3-16. PubMed ID: 12802585
[TBL] [Abstract][Full Text] [Related]
18. Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase.
Azevedo EP; Guimarães-Costa AB; Torezani GS; Braga CA; Palhano FL; Kelly JW; Saraiva EM; Foguel D
J Biol Chem; 2012 Oct; 287(44):37206-18. PubMed ID: 22918834
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.
Jayaraman S; Gantz DL; Haupt C; Gursky O
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6507-E6515. PubMed ID: 28743750
[TBL] [Abstract][Full Text] [Related]
20. The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.
Iannuzzi C; Irace G; Sirangelo I
Molecules; 2015 Feb; 20(2):2510-28. PubMed ID: 25648594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
